476 related articles for article (PubMed ID: 10027415)
21. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo.
Zeng X; Wert SE; Federici R; Peters KG; Whitsett JA
Dev Dyn; 1998 Mar; 211(3):215-27. PubMed ID: 9520109
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system.
Kremer C; Breier G; Risau W; Plate KH
Cancer Res; 1997 Sep; 57(17):3852-9. PubMed ID: 9288799
[TBL] [Abstract][Full Text] [Related]
23. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression.
Mukhopadhyay D; Tsiokas L; Sukhatme VP
Cancer Res; 1995 Dec; 55(24):6161-5. PubMed ID: 8521408
[TBL] [Abstract][Full Text] [Related]
24. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
[TBL] [Abstract][Full Text] [Related]
25. Host microvasculature influence on tumor vascular morphology and endothelial gene expression.
Roberts WG; Delaat J; Nagane M; Huang S; Cavenee WK; Palade GE
Am J Pathol; 1998 Oct; 153(4):1239-48. PubMed ID: 9777955
[TBL] [Abstract][Full Text] [Related]
26. KDR activation in astrocytic neoplasms.
Carroll RS; Zhang J; Bello L; Melnick MB; Maruyama T; McL Black P
Cancer; 1999 Oct; 86(7):1335-41. PubMed ID: 10506722
[TBL] [Abstract][Full Text] [Related]
27. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
28. Angiogenesis in malignant gliomas.
Plate KH; Risau W
Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
[TBL] [Abstract][Full Text] [Related]
29. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
30. Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds.
Krum JM; Rosenstein JM
Exp Neurol; 1999 Dec; 160(2):348-60. PubMed ID: 10619552
[TBL] [Abstract][Full Text] [Related]
31. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
Guo P; Xu L; Pan S; Brekken RA; Yang ST; Whitaker GB; Nagane M; Thorpe PE; Rosenbaum JS; Su Huang HJ; Cavenee WK; Cheng SY
Cancer Res; 2001 Dec; 61(23):8569-77. PubMed ID: 11731444
[TBL] [Abstract][Full Text] [Related]
33. No complementation between TP53 or RB-1 and v-src in astrocytomas of GFAP-v-src transgenic mice.
Maddalena AS; Hainfellner JA; Hegi ME; Glatzel M; Aguzzi A
Brain Pathol; 1999 Oct; 9(4):627-37. PubMed ID: 10517501
[TBL] [Abstract][Full Text] [Related]
34. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
[TBL] [Abstract][Full Text] [Related]
35. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.
Endo T; Kitajima Y; Nishikawa A; Manase K; Shibuya M; Kudo R
Fertil Steril; 2001 Oct; 76(4):762-8. PubMed ID: 11591411
[TBL] [Abstract][Full Text] [Related]
36. Expression of vascular endothelial growth factor-b in human astrocytoma.
Gollmer JC; Ladoux A; Gioanni J; Paquis P; Dubreuil A; Chatel M; Frelin C
Neuro Oncol; 2000 Apr; 2(2):80-6. PubMed ID: 11303624
[TBL] [Abstract][Full Text] [Related]
37. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
[TBL] [Abstract][Full Text] [Related]
38. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.
He Y; Smith SK; Day KA; Clark DE; Licence DR; Charnock-Jones DS
Mol Endocrinol; 1999 Apr; 13(4):537-45. PubMed ID: 10194760
[TBL] [Abstract][Full Text] [Related]
39. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
[TBL] [Abstract][Full Text] [Related]
40. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
